Abbott Laboratories to pay $670 million to settle infant formula litigation

Abbott Laboratories has reached a $670 million settlement to resolve a portion of ongoing lawsuits regarding its infant formula products. The company characterizes this as a significant step toward broader litigation resolution, though the total remaining liability and specific legal exposure remain subject to further court proceedings.